Oncotarget

Research Papers:

Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients

Guilherme Augusto Silva Nogueira, Ericka Francislaine Dias Costa, Leisa Lopes-Aguiar, Tathiane Regine Penna Lima, Marília Berlofa Visacri, Eder Carvalho Pincinato, Gustavo Jacob Lourenço, Luciane Calonga, Fernanda Viviane Mariano, Albina Messias de Almeida Milani Altemani, João Maurício Carrasco Altemani, Patrícia Moriel, Carlos Takahiro Chone, Celso Dario Ramos and Carmen Silvia Passos Lima _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:29538-29547. https://doi.org/10.18632/oncotarget.25268

Metrics: PDF 1790 views  |   HTML 2745 views  |   ?  


Abstract

Guilherme Augusto Silva Nogueira1, Ericka Francislaine Dias Costa1, Leisa Lopes-Aguiar1, Tathiane Regine Penna Lima1, Marília Berlofa Visacri2, Eder Carvalho Pincinato1, Gustavo Jacob Lourenço3, Luciane Calonga4, Fernanda Viviane Mariano5, Albina Messias de Almeida Milani Altemani5, João Maurício Carrasco Altemani6, Patrícia Moriel2, Carlos Takahiro Chone4, Celso Dario Ramos6 and Carmen Silvia Passos Lima1

1Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

2Department of Clinical Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

3Laboratory of Cancer Genetics, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

4Department of Ophthalmology and Otorhinolaryngology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

5Department of Pathology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

6Department of Radiology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil

Correspondence to:

Carmen Silvia Passos Lima, email: [email protected]

Keywords: head and neck squamous cell carcinoma; mismatch repair pathway; single nucleotide polymorphism; outcome

Received: February 03, 2018     Accepted: March 26, 2018     Published: July 03, 2018

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is treated with cisplatin (CDDP) and radiotherapy (RT), and distinct results are observed among patients with similar clinicopathological aspects. This prospective study aimed to investigate whether MLH1 c.-93G>A (rs1800734), MSH2 c.211+9C>G (rs2303426), MSH3 c.3133G>A (rs26279), EXO1 c.1765G>A (rs1047840), and EXO1 c.2270C>T (rs9350) single nucleotide polymorphisms (SNPs) of the mismatch repair (MMR) pathway change side effects and response rate of 90 HNSCC patients treated with CDDP and RT. DNA from peripheral blood was analyzed by PCR-based methods to obtain genotypes. It was observed 4.27-fold and 4.69-fold increased risks of presenting pronounced nephrotoxicity with treatment in patients with MSH3 GG and EXO1 rs9350 CC genotypes compared with patients with GA or AA and CT or TT genotypes, respectively. MSH3 GG or GA and GT haplotype of EXO1 rs1047840 and rs9350 SNPs conferred to patients 10.29 and 4.00 more chances of presenting pronounced ototoxicity after treatment than MSH3 AA genotype and other EXO1 haplotypes, respectively. Patients with EXO1 rs1047840 GA or AA genotype and AC haplotype of EXO1 rs1047840 and rs9350 SNPs had both 9.55-fold increased risks of achieving partial response or stable disease instead of complete remission after treatment than patients with EXO1 GG genotype and other EXO1 haplotypes, respectively. For the first time, our data show preliminary indication that inherited alterations of DNA MMR pathway, related to MSH3 rs26279, EXO1 rs1047840 and EXO1 rs9350 SNPs, modify toxicity and response to chemoradiation in HNSCC, and may contribute to future personalized treatment of patients.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25268